Following New York state guidance, MSK has suspended offering the J & J/Janssen vaccine. We continue to offer the Pfizer-BioNTech and Moderna vaccines to our eligible patients. Appointments can be scheduled here. For more on the J & J vaccine, read this.
My current research is focused on adaptive resistance mechanism of KRAS mutant cancer cells, especially to KRASG12C-specific inhibitor. I aim to contribute to improving the outcome of patients with KRAS mutant cancer.